5 Must Watch Items as Aurora Cannabis (TSX:ACB) Reports Quarterly Earnings on Thursday

Leading marijuana producer Aurora Cannabis (TSX:ACB)(NYSE:ACB) is set to release its fiscal first quarter 2020 results for the period ended September 30 after market close on November 14. Management has strictly refrained from giving any prior earnings guidance this time, which is understandable after some recent humiliation where both revenue and adjusted earnings before interest, tax, depreciation, and amortization (EBITDA)…

Read More

Could Canopy Growth’s (TSX:WEED) Drake Partnership Bring the Stock Back to Life?

The TSX has been on fire lately, setting record highs and rising through the month of November. But don’t tell that to Canopy Growth (TSX:WEED)(NYSE:CGC) investors, who’ve seen their holdings stagnate while the rest of the market has been soaring. Owing to a recent $1.23 billion loss, Canopy shares have taken a beating in the markets. Starting off the year at $39,…

Read More

Captor Capital Announces Changes to Board of Directors

TORONTO, Nov. 12, 2019 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; FRANKFURT: NMV; STUTTGART: NMVA; USOTC: CPTRF), (“Captor” or the “Company”), an integrated cannabis company, today appointed Bryan Reyhani to the Board of Directors as an Independent Director. Mr. Reyhani has two decades of legal and business experience and has handled various investor, regulatory, financing, and corporate governance matters…

Read More

Is HEXO (TSX:HEXO) Stock a Contrarian Buy?

The high-flying cannabis sector has hit some turbulence in the past six months and investors are wondering whether the pullback has simply gone too far. Volatility in marijuana stocks is not new and investors should expect that trend to continue as the sector works through the growing pains associated with the emergence of a new industry. Analysts and investors agree…

Read More

Marijuana Stocks: Has Canopy Growth (TSX:WEED) Reached a Bottom?

The downward spiral that hit Canada’s marijuana sector continues unabated. Canopy Growth (TSX:WEED)(NYSE:CGC), the world’s largest cannabis producer, has lost more than 60% of its value since hitting a record high in April. The major question before investors after this massive correction is, are these beaten-down stocks close to reaching a bottom? Investors are selling marijuana stocks amid disappointing results, regulatory…

Read More

Marijuana Investors: 1 Easy Way to Protect Yourself From Tanking Pot Stocks

It has not been a good few months for Canada’s top marijuana companies. Shares have tanked as investors have suddenly turned bearish on the sector. There are a few things that are conspiring against pot stocks to keep them down. Many analysts are saying a wave of oversupply is on the verge of hitting the market, which will drive down…

Read More

Cannabis Investors: Aphria’s (TSX:APHA) Latest Licence Win Opens Up New Growth Opportunities

News on Monday revealed that marijuana producer Aphria (TSX:APHA)(NYSE:APHA) has finally obtained its long-awaited grow licences from Health Canada at its biggest facility in a development that allows the firm to double its annual production capacity to 255,000 kilograms of pot next year. The stock price didn’t respond positively to the announcement. The share price actually declined during the day.…

Read More

Better Cannabis Buy: Cronos (TSX:CRON) vs. Tilray (NASDAQ:TLRY)

Cannabis investors continue to experience a steep decline in the value of their investments. However, several cannabis stocks are trading close to their 52-week lows and might gain in market value as we head into 2020. Here, we look at two stocks that have corrected significantly in the last year. The stocks are Cronos (TSX:CRON)(NASDAQ:CRON) and Tilray (NASDAQ:TLRY). Cronos went…

Read More

KALY – Kali-Extracts Confirms $50 Million Valuation Of Its Cannabis Biopharmaceutical Technology

Kali Extracts

DALLAS, Nov. 01, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed an investor interested in acquiring KALY’s U.S. Patented Cannabis Extraction Process and related biopharmaceutical technology has valued the technology at $50 million. Yesterday KALY announced taking a next step with the investor to explore a possible sale.…

Read More

New to Cannabis? 2 Promising Pot Stocks for Beginners

The cannabis market is set for massive growth. You probably already know that, yet the numbers are worth repeating. Over the next decade, global sales are expected to grow by more than 20% per year. By 2030, some analysts believe the market will be worth $100 billion. Research firms like Stifel Financial think it can ultimately reach $200 billion in annual…

Read More